Therasystemo: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Therasystemo
Largest movements
- Cash +€8,763
up €8,763 (+20.6%), from €42,604 to €51,367
mainly Net result for the year (+€8,737) and Trade debts (+€183)
- Reserves +€8,737
up €8,737 (+28.7%), from €30,450 to €39,187
of which Distributable reserves: +€8,737
- Financial income -€185
down €185 (-36.2%), from €511 to €326
- Taxes +€172
up €172 (+3.8%), from €4,550 to €4,722
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €43,676 | €52,540 | +€8,864 | +20.3% |
| Current assets | 29/58 | €43,676 | €52,540 | +€8,864 | +20.3% |
| Amounts receivable within one year | 40/41 | - | €195 | +€195 | |
| Trade receivables | 40 | - | €195 | +€195 | |
| Cash at bank and in hand | 54/58 | €42,604 | €51,367 | +€8,763 | +20.6% |
| Deferred charges and accrued income | 490/1 | €1,072 | €978 | -€94 | -8.8% |
| Total equity and liabilities | 10/49 | €43,676 | €52,540 | +€8,864 | +20.3% |
| Equity | 10/15 | €42,891 | €51,628 | +€8,737 | +20.4% |
| Contributions | 10/11 | €12,400 | €12,400 | = | 0.0% |
| Reserves | 13 | €30,450 | €39,187 | +€8,737 | +28.7% |
| Non-distributable reserves | 130/1 | €1,860 | €1,860 | = | 0.0% |
| Reserves not available under the articles | 1311 | €1,860 | €1,860 | = | 0.0% |
| Distributable reserves | 133 | €28,590 | €37,327 | +€8,737 | +30.6% |
| Profit (loss) carried forward | 14 | €41 | €41 | = | 0.0% |
| Amounts payable | 17/49 | €785 | €912 | +€127 | +16.2% |
| Amounts payable within one year | 42/48 | €785 | €892 | +€107 | +13.6% |
| Trade debts | 44 | €12 | €195 | +€183 | +1521.9% |
| Suppliers | 440/4 | €12 | €195 | +€183 | +1521.9% |
| Taxes, remuneration and social security | 45 | €517 | €641 | +€124 | +24.1% |
| Taxes | 450/3 | €517 | €641 | +€124 | +24.1% |
| Other amounts payable | 47/48 | €256 | €56 | -€200 | -78.0% |
| Accrued charges and deferred income | 492/3 | - | €20 | +€20 | |
| Other operating charges | 640/8 | €679 | €696 | +€17 | +2.4% |
| Gross operating margin | 9900 | €13,857 | €13,965 | +€109 | +0.8% |
| Operating profit (loss) | 9901 | €13,178 | €13,270 | +€92 | +0.7% |
| Financial income | 75/76B | €511 | €326 | -€185 | -36.2% |
| Recurring financial income | 75 | €511 | €326 | -€185 | -36.2% |
| Financial charges | 65/66B | €235 | €137 | -€99 | -41.9% |
| Recurring financial charges | 65 | €235 | €137 | -€99 | -41.9% |
| Profit (loss) for the period before taxes | 9903 | €13,453 | €13,459 | +€6 | 0.0% |
| Income taxes | 67/77 | €4,550 | €4,722 | +€172 | +3.8% |
| Profit (loss) for the period | 9904 | €8,903 | €8,737 | -€166 | -1.9% |
| Profit (loss) for the period to be appropriated | 9905 | €8,903 | €8,737 | -€166 | -1.9% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 6 October 2026 via checked.be.